Stig Einride Larsen - Epidemiology

Author Information

Stig Einride Larsen is affiliated with the Digestive Disease Center, Centre for Epidemiology and Biostatistics at the Norwegian University of Life Sciences in Oslo, Norway. He is a prolific researcher with a focus on epidemiology and biostatistics, contributing significantly to the scientific community through his extensive research and publications.

Research Contributions

Stig Einride Larsen has made substantial contributions to the field of epidemiology and biostatistics. His research encompasses various topics such as response surface pathway design, the efficacy and tolerability of treatments for metastatic breast cancer, osteopathic manual therapy in treating gastroesophageal reflux disease (GERD), and the use of visual analogue scales in radiologic subjective image quality assessment. His work often involves randomized, double-blind, placebo-controlled studies, highlighting his commitment to rigorous scientific methods and evidence-based conclusions.

Aliases

Stig Einride Larsen is also known by several other names in academic publications, including S Larsen, S. Larsen, and Stig Larsen.

Publication and Citation Metrics

Metric	Value
Total Citations	1826
H-index	18
Total Publications	63

Publications:

Randomized response surface pathway design with skewed starting point and stochastic dose window

DOI: 10.18203/2349-3259.ijct20200202

Year: 2020

Randomized two dimensional between patient response surface pathway design with two interventional and one response variable in estimating minimum efficacy dose

DOI: 10.18203/2349-3259.IJCT20193210

Year: 2019

BP-C1 in treatment of pretreated metastatic breast cancer: A meta-analysis of two randomized, double-blind and placebo-controlled multicenter studies.

DOI: 10.1200/jgo.2019.5.suppl.12

Year: 2019

Efficacy and tolerability of BPC 1 in metastatic breast cancer : a Phase II , randomized , double-blind , and placebo-controlled Thai multi-center study

DOI:

Year: 2019

Osteopathic manual therapy (OMT) in treatment of gastroesophageal reflux disease (GERD)

DOI: 10.4172/clinical-practice.1000453

Year: 2019

Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

DOI: 10.2147/BCTT.S174298

Year: 2019

Randomized Two-Dimensional between-Patient Response Surface Pathway Design with Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose

DOI: 10.4172/2167-0870.1000353

Year: 2018

Can visual analogue scale be used in radiologic subjective image quality assessment?

DOI: 10.1007/s00247-018-4187-8

Year: 2018

Do the efficacy of BP-C1 correlate to receptor status in patients suffering from metastatic breast cancer stage IV?

DOI: 10.1200/JCO.2017.35.15_suppl.e12581

Year: 2017

The Effect of Osteopathic Manipulation Therapy (OMT) in Patients with Gastroesophageal Reflux Disease (GERD)

DOI: 10.15344/2456-3501/2017/132

Year: 2017

What is Evidence-Based Treatment?

How is Safety Equipment Used?

Why Was Vioxx Withdrawn?

How Do Surgical Techniques Relate to Epidemiology?

Why is Ventilation Important in Epidemiology?

What Role Does Data Play in Precision Public Health?

How Do pH Levels Influence Disease Treatment and Management?

What are Some Real-World Applications of IP in Epidemiology?

What are the Challenges of CEA in Epidemiology?

What Are the Major Sources of Water Contamination?

Partnered Content Networks

Relevant Topics